Cargando…
Deep survey for designing a vaccine against SARS-CoV-2 and its new mutations
The ongoing global pandemic caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has prompted worldwide vaccine development. Several vaccines have been authorized by WHO, FDA, or MOH of different countries. However, issues such as need for cold chain, price, and most importantly ac...
Autores principales: | Vakili, Bahareh, Bagheri, Ashkan, Negahdaripour, Manica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369332/ https://www.ncbi.nlm.nih.gov/pubmed/34421121 http://dx.doi.org/10.1007/s11756-021-00866-y |
Ejemplares similares
-
Administration of COVID-19 vaccines in immunocompromised patients
por: Negahdaripour, Manica, et al.
Publicado: (2021) -
COVID-19 Vaccine Global Access Is an Urgency
por: Negahdaripour, Manica
Publicado: (2021) -
In silico design and evaluation of a novel mRNA vaccine against BK virus: a reverse vaccinology approach
por: Mohammadi, Yasaman, et al.
Publicado: (2022) -
Hotspots for mutations in the SARS-CoV-2 spike glycoprotein: a correspondence analysis
por: Rahbar, Mohammad Reza, et al.
Publicado: (2021) -
The Battle Against COVID-19: Where Do We Stand Now?
por: Negahdaripour, Manica
Publicado: (2020)